Related Experiment Video
Updated: Apr 30, 2026
10:15
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
1.8K
Osteoprotegerin and kidney disease
Alejandra Montañez-Barragán1, Isaias Gómez-Barrera1, Maria D Sanchez-Niño2,3
1Escuela Superior de Medicina del Instituto Politécnico Nacional, Ciudad de México, Mexico.
Journal of Nephrology
|April 24, 2014
Summary
Osteoprotegerin (OPG) is elevated in chronic kidney disease (CKD) and may indicate vascular calcification and survival. While OPG levels rise with kidney disease, it may offer protective benefits against tissue injury.
Area of Science:
- Nephrology
- Vascular Biology
- Biochemistry
Background:
- Vascular calcification in chronic kidney disease (CKD) is linked to higher mortality.
- Osteoprotegerin (OPG) is a protein that inhibits vascular calcification and apoptosis.
- OPG plays a role in regulating vascular health and kidney function.
Purpose of the Study:
- To investigate the role of Osteoprotegerin (OPG) as a biomarker and potential therapeutic agent in chronic kidney disease (CKD).
- To analyze OPG levels in various stages of CKD and its association with vascular calcification and patient survival.
Main Methods:
- Review of existing literature on OPG in CKD.
- Analysis of OPG levels in predialysis, dialysis, and transplant CKD patients.
- Examination of urinary OPG in human kidney disease.
- Assessment of OPG's protective effects in experimental models.
Main Results:
- Circulating OPG levels are elevated in CKD patients and correlate with vascular calcification progression and survival.
- Urinary OPG is also increased in kidney disease, potentially indicating disease activity.
- OPG deficiency leads to vascular calcification, while OPG itself prevents calcification in cell cultures.
- OPG demonstrated protective effects in kidney cells and may be protective against vascular injury in uremia.
Conclusions:
- OPG may serve as a valuable biomarker for vascular calcification and prognosis in CKD patients.
- Despite elevated levels in disease, OPG exhibits protective properties, suggesting therapeutic potential.
- Further research is warranted to fully elucidate the therapeutic and biomarker utility of OPG in kidney disease.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
679
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
01:29Acute Kidney Injury II: Pathophysiology
2.3K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.3K
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
559
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
01:25Chronic Kidney Disease I: Introduction
1.4K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
01:24Chronic Kidney Disease II: Clinical Manifestations
1.1K
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
01:28Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32